COVID-19, shock séptico refractario y terapia extracorpórea de purificación sanguínea con OXIRIS®
- Autores: Gonzalo Ramírez-Guerrero, Romyna Baghetti-Hernández, Cristian Godoy-Tello, Francisco Villagrán-Cortés, Vicente Torres-Cifuentes, Osvaldo Garay-Coloma
- Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 150, Nº. 2, 2022, págs. 266-270
- Idioma: español
- Títulos paralelos:
- Management of refractory septic shock with blood purification therapy using a special filter. Report of one case
- Enlaces
-
Resumen
Sepsis is one of the leading causes of death in critically ill patients with COVID-19 and blood purification therapies have a role to immunomodulate the excessive inflammatory response and improve clinical results. One of the devices designed for these therapies is the oXiris® filter, allowing to perform renal replacement therapy combined with selective adsorption of endotoxins and cytokines. We report a 55-year-old male with COVID who developed a septic shock secondary to a sepsis caused by Pseudomona aeruginosa, refractory to the usual management. A veno-venous continuous hemofiltration was started using the oXiris® filter for 48 hours. Subsequently, there was an improvement in clinical perfusion parameters and a reduction in inflammatory markers. The patient was discharged from the intensive care one month later.
